HSF1 (Ab-142) Antibody

What is HSF1 (Ab-142) Antibody and what is its target specificity?

HSF1 (Ab-142) Antibody is a rabbit polyclonal antibody designed to detect endogenous levels of total HSF1 protein. This antibody was generated against a synthesized non-phosphopeptide derived from human HSF1 surrounding the threonine 142 phosphorylation site, with the specific sequence L-L-T(p)-D-V . The antibody has been affinity-purified from rabbit antiserum using epitope-specific immunogen-based affinity chromatography, enhancing its specificity and reducing background signal . It recognizes the total HSF1 protein rather than specifically detecting the phosphorylated form at threonine 142 .

The antibody detects HSF1 with an expected molecular weight of approximately 57 kDa in SDS-PAGE, though it may appear at a higher molecular weight (~85 kDa) in some experimental systems due to post-translational modifications like phosphorylation . This antibody has been primarily validated for human samples but may have cross-reactivity with HSF1 from other species depending on epitope conservation .

What are the validated applications and experimental conditions for this antibody?

The HSF1 (Ab-142) Antibody has been primarily validated for Western blot (WB) applications with a recommended dilution range of 1:500 to 1:3000 . In particular, it has demonstrated effectiveness in detecting endogenous HSF1 in K562 cell extracts, making these cells a suitable positive control for optimization experiments .

For optimal Western blot results, the manufacturer recommends using the antibody at a 1:1000 dilution in a colorimetric detection system . The antibody is supplied at a concentration of 1 mg/ml in a stabilizing buffer consisting of phosphate-buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150 mM NaCl, 0.02% sodium azide, and 50% glycerol . This formulation ensures antibody stability during storage at the recommended temperature of -20°C .

While immunohistochemistry on paraffin sections (IHC-PS) is listed as a potential application for some HSF1 antibodies, specific validation data for the HSF1 (Ab-142) Antibody in this application was not provided in the search results .

What is the biological significance of HSF1 and the region around threonine 142?

HSF1 (Heat Shock Factor 1) is a DNA-binding transcription factor that specifically recognizes and binds to heat shock promoter elements (HSE) in the promoter regions of heat shock genes . Upon exposure to various stresses, particularly heat shock, HSF1 undergoes rapid translocation from the cytoplasm to the nucleus, where it forms discrete nuclear granules and activates the transcription of heat shock proteins (HSPs) .

The region around threonine 142 represents one of the many phosphorylation sites on HSF1. Research has identified up to 73 phosphorylation sites among the 153 total serine and threonine residues in HSF1 . Phosphorylation of HSF1 appears to positively tune its transcriptional activity during stress responses . The specific contribution of threonine 142 phosphorylation to HSF1 function hasn't been fully characterized according to the search results, but it is located within a region that may influence HSF1's transcriptional activity or protein-protein interactions .

Interestingly, research indicates that HSF1 can also act as a transcriptional repressor for certain genes. For example, HSF1 has been shown to suppress the expression of surfactant protein D (SFTPD), with the core suppression site residing in the region from −142 to −134 bp of the SFTPD promoter .

What are the recommended protocols for using HSF1 (Ab-142) Antibody in Western blot experiments?

For optimal Western blot results with HSF1 (Ab-142) Antibody, the following protocol is recommended:

• Sample preparation: Extract total protein from cells or tissues using a standard lysis buffer with protease and phosphatase inhibitors to preserve HSF1 and its phosphorylation status.

• Protein quantification: Determine protein concentration using a standard assay (BCA or Bradford).

• SDS-PAGE: Load 20-50 μg of protein per lane on an SDS-PAGE gel (8-10% is appropriate for resolving the ~57 kDa HSF1 protein).

• Transfer: Transfer proteins to a PVDF or nitrocellulose membrane using standard transfer methods.

• Blocking: Block the membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute HSF1 (Ab-142) Antibody 1:1000 in blocking buffer and incubate overnight at 4°C with gentle agitation .

• Washing: Wash the membrane 3-4 times with TBST, 5 minutes each.

• Secondary antibody: Incubate with an appropriate anti-rabbit IgG HRP-conjugated secondary antibody (typically at 1:5000 dilution) for 1 hour at room temperature .

• Detection: After washing, develop using ECL substrate and detect using an appropriate imaging system.

K562 cells have been validated as a positive control for this antibody, as demonstrated in the provided Western blot images . When optimizing conditions, researchers should be aware that HSF1 may appear at approximately 57 kDa according to its predicted size, but may migrate at a higher apparent molecular weight (up to 85 kDa) due to post-translational modifications .

What controls should be included when using HSF1 (Ab-142) Antibody?

To ensure reliable and interpretable results with HSF1 (Ab-142) Antibody, the following controls should be included:

• Positive control: Include lysates from cell lines known to express HSF1, such as K562 cells, which have been validated with this antibody . This control confirms the antibody is functioning as expected.

• Negative control: When possible, include HSF1 knockdown or knockout samples to confirm the specificity of the detected band. For immunoprecipitation experiments, an isotype-matched IgG control should be used to identify potential non-specific binding.

• Loading control: Include detection of a housekeeping protein (e.g., GAPDH, β-actin) to normalize for variations in protein loading across samples.

• Treatment controls: When studying HSF1 activation, include both untreated and heat-shocked samples. Research shows that heat shock induces rapid translocation of HSF1 to the nucleus and changes in its phosphorylation status, providing a functional control for HSF1 activity .

• Tissue/cell specificity controls: When working with different cell types or tissues, include samples known to have variable HSF1 expression to validate detection across experimental systems.

For phosphorylation studies, consider including phosphatase-treated samples as an additional control to confirm that mobility shifts or intensity changes are due to phosphorylation events, which is particularly relevant when studying HSF1 given its extensive phosphorylation profile (up to 73 sites) .

How can I validate the specificity of HSF1 (Ab-142) Antibody in my experimental system?

Validating antibody specificity is crucial for generating reliable data. For HSF1 (Ab-142) Antibody, consider these validation approaches:

• Molecular weight verification: Confirm that the detected band appears at the expected molecular weight for HSF1 (~57 kDa, though it may migrate at a higher apparent weight due to post-translational modifications) .

• siRNA/shRNA knockdown: Perform HSF1 knockdown experiments using RNA interference and confirm reduced signal intensity corresponding to HSF1 depletion.

• Overexpression: In cells with low endogenous HSF1, overexpress tagged HSF1 and confirm increased signal intensity at the appropriate molecular weight.

• Peptide competition: Pre-incubate the antibody with the immunizing peptide (the non-phosphorylated peptide around threonine 142) before application to the membrane. This should significantly reduce or eliminate specific binding.

• Multiple antibody validation: Compare results with other validated HSF1 antibodies targeting different epitopes to confirm consistent detection patterns.

• Heat shock response: As a functional validation, treat cells with heat shock and confirm expected changes in HSF1 localization (cytosol to nucleus) and/or mobility shifts in Western blot due to increased phosphorylation .

• Cross-reactivity assessment: Test the antibody against samples from different species to determine cross-reactivity, particularly if working with non-human experimental systems.

These validation steps will help ensure that the observed signals are truly representative of HSF1 and not artifacts or non-specific binding.

How can I use HSF1 (Ab-142) Antibody to study HSF1 phosphorylation dynamics?

While HSF1 (Ab-142) Antibody recognizes total HSF1 rather than specifically phosphorylated forms, it can still be valuable for studying phosphorylation dynamics through several approaches:

• Mobility shift analysis: Phosphorylation often causes HSF1 to migrate more slowly in SDS-PAGE, appearing as upward band shifts. Using HSF1 (Ab-142) Antibody in Western blot analysis of samples collected at different time points during stress responses can reveal these phosphorylation-induced mobility shifts .

• Phosphatase treatment: Compare samples with and without phosphatase treatment to confirm that observed mobility shifts are due to phosphorylation. This can be particularly informative when combined with time-course experiments during heat shock and recovery .

• Complementary phospho-specific antibodies: Use HSF1 (Ab-142) Antibody in conjunction with available phospho-specific antibodies targeting other HSF1 phosphorylation sites to develop a comprehensive profile of HSF1 phosphorylation states.

• Mass spectrometry analysis: Immunoprecipitate HSF1 using HSF1 (Ab-142) Antibody followed by mass spectrometry to identify and quantify specific phosphorylation sites and how they change during stress responses .

Research has revealed that HSF1 can be phosphorylated at up to 73 out of 153 total serine and threonine residues under various conditions . Surprisingly, studies with mutant variants of HSF1 suggest that while phosphorylation contributes to HSF1 regulation, it exhibits remarkable functional redundancy. Even an HSF1 variant with 152 serine/threonine residues mutated to alanine (preserving only S225 for DNA binding) maintained normal subcellular localization and DNA-binding capacity, though this mutant showed no 32P incorporation during heat shock .

What approaches can I use to study HSF1's role in cancer biology?

HSF1 plays critical roles in cancer development and progression, making it an important subject for cancer research. Using HSF1 (Ab-142) Antibody, researchers can investigate:

• HSF1 expression levels: Compare HSF1 protein levels between normal and cancer cells/tissues using Western blot analysis. Research indicates HSF1 activity is often constitutively elevated in cancer cells compared to normal cells .

• HSF1-dependent oncoprotein stability: Investigate how HSF1 depletion or inhibition affects the stability of known oncoproteins such as ERBB2/HER2, c-MET, CYCLIN D1, CDK4, BRAF, AKT, and mutant forms like BCR-ABL, EML4-ALK, and mutant TP53 .

• HSF1-c-MYC interactions: Examine how HSF1 potentiates c-MYC transcriptional activity in cancer cells. Research suggests HSF1 specifically enhances c-MYC-mediated transcription by facilitating c-MYC-GCN5 association, distinct from its canonical heat shock response function .

• HSF1 knockdown effects: Analyze the consequences of HSF1 depletion on cancer cell viability, growth, and apoptosis. Studies have shown that HSF1 depletion markedly impairs growth and survival of diverse cancer cell lines, induces apoptosis in multiple myeloma cells, and compromises viability of various tumor types .

• HSF1's role in proteostasis: Investigate how HSF1 helps maintain proteome stability in cancer cells, which often experience chronic proteotoxic stress. HSF1 activates heat shock proteins that maintain functional conformations of numerous oncoproteins and prevent the formation of toxic protein aggregates .

Research has shown that while HSF1 is dispensable for cellular viability under normal non-stressed conditions, cancer cells appear to exhibit constitutive HSF1 activation, suggesting they experience chronic proteotoxic stress . This cancer-specific dependency makes HSF1 an attractive therapeutic target.

How can I investigate the dynamic interaction between HSF1 and molecular chaperones?

The interaction between HSF1 and molecular chaperones, particularly Hsp70, represents a key regulatory mechanism for HSF1 activity. To study these dynamics:

• Co-immunoprecipitation time course: Use HSF1 (Ab-142) Antibody to immunoprecipitate HSF1 at different time points during heat shock and recovery, then blot for chaperone proteins. Research has revealed that Hsp70 chaperones (Ssa1/2) are the primary proteins that co-precipitate with HSF1 under basal conditions, but this interaction changes dynamically during stress responses .

• Reverse co-IP: Immunoprecipitate Hsp70 and blot for HSF1 to confirm the interaction from both perspectives.

• Time-course analysis: Research indicates that Hsp70-HSF1 interaction follows a specific temporal pattern during heat shock - Hsp70 associates with HSF1 under basal conditions, dissociates during early heat shock (within 5 minutes), and then reassociates at later time points as the heat shock response attenuates .

• Fractionation studies: Combine cellular fractionation with co-IP to determine where in the cell these interactions occur, particularly since HSF1 translocates from cytosol to nucleus during heat shock .

• Functional consequences: Investigate how disrupting the HSF1-chaperone interaction affects HSF1 transcriptional activity using reporter gene assays or transcriptome analysis.

Mass spectrometry analysis of HSF1 immunoprecipitates has revealed that cytosolic Hsp70 chaperones are the predominant HSF1 interactors under basal conditions . Notably, contrary to some models, peptides belonging to Hsp90 or other chaperones were not identified in HSF1 immunoprecipitates, suggesting that Hsp70 is the primary regulator of HSF1 . This chaperone switch mechanism complements phosphorylation-based regulation and plays a crucial role in the dynamic control of HSF1 during stress responses.

Why might I observe multiple bands or unexpected band sizes when using HSF1 (Ab-142) Antibody?

When using HSF1 (Ab-142) Antibody, you might encounter multiple bands or unexpected band sizes for several reasons:

• Post-translational modifications: HSF1 undergoes extensive phosphorylation (up to 73 sites identified) and other modifications that can alter its migration pattern . This commonly results in HSF1 appearing at a higher molecular weight than its predicted 57 kDa - sometimes up to 85 kDa .

• Stress-induced modifications: Heat shock or other stresses induce additional phosphorylation events, causing further mobility shifts that can appear as distinct bands or smears .

• Proteolytic degradation: Inadequate protease inhibition during sample preparation may result in partial degradation products appearing as lower molecular weight bands.

• Isoforms or splice variants: While less common for HSF1, alternative splicing could produce different protein isoforms.

• Cross-reactivity: The antibody might recognize related proteins in the HSF family (HSF2-4) if there is sequence homology in the epitope region.

To address these issues:

• Use fresh samples with appropriate protease and phosphatase inhibitors

• Compare samples with and without stress treatments to identify stress-induced shifts

• Optimize sample preparation, gel percentage, and running conditions

• Include known positive controls like K562 cell lysates

• Consider phosphatase treatment of parallel samples to collapse phosphorylation-dependent band shifts

Remember that the predicted molecular weight (57 kDa) may differ from the observed size due to these factors, particularly post-translational modifications .

What are common pitfalls when studying HSF1 phosphorylation and how can I avoid them?

Studying HSF1 phosphorylation presents several challenges that researchers should be aware of:

• Complex phosphorylation profile: HSF1 contains up to 73 phosphorylation sites, making it difficult to attribute functional outcomes to individual sites . Rather than focusing on single sites, consider studying clusters of phosphorylation sites or using broad phosphorylation detection methods.

• Functional redundancy: Research shows that mutation of individual phosphorylation sites, including threonine 142, often has minimal effects on HSF1 function due to compensatory mechanisms . Even mutating multiple sites may not yield clear phenotypes, as demonstrated by studies showing that HSF1 with 152 out of 153 serine/threonine residues mutated to alanine still maintained normal DNA binding capabilities .

• Rapid and dynamic changes: HSF1 phosphorylation changes quickly during stress responses, potentially within minutes of heat shock . Design time-course experiments with appropriate temporal resolution to capture these dynamics.

• Context-dependency: HSF1 phosphorylation patterns and their functional consequences may vary significantly between cell types, organisms, and stress conditions. Include appropriate controls and be cautious when generalizing findings across systems.

• Technical considerations: Phosphorylation can affect antibody binding, potentially altering detection efficiency. When possible, complement Western blot analyses with phospho-specific antibodies, phosphatase treatments, and mass spectrometry to build a comprehensive view of HSF1 phosphorylation.

To avoid these pitfalls, design experiments that account for the complex and redundant nature of HSF1 regulation, including both phosphorylation and non-phosphorylation mechanisms like the chaperone switch involving Hsp70 .

How should I interpret HSF1 data across different experimental systems?

When comparing HSF1 data across different experimental systems, consider these important factors:

• Species differences: HSF1 regulation varies between organisms. For example, yeast Hsf1 shows differences in regulatory mechanisms compared to mammalian HSF1 . The HSF1 (Ab-142) Antibody was raised against human HSF1, so cross-reactivity with HSF1 from other species may vary depending on epitope conservation .

• Normal versus cancer cells: HSF1 appears constitutively active in many cancer cells but shows transient activation in normal cells only under stress conditions . This fundamental difference can lead to divergent results when comparing HSF1 function, localization, or modification patterns between normal and cancer models.

• Cell-type specific factors: Different cell types may express varying levels of HSF1 regulators, including Hsp70 chaperones, which can influence HSF1 activity and response patterns .

• Stress protocols: The nature, intensity, and duration of stress treatments (e.g., heat shock temperature and time) significantly impact HSF1 activation, phosphorylation, and chaperone interactions . Standardize stress protocols when making comparisons.

• Basal stress levels: Standard culture conditions may impose varying levels of basal stress, affecting HSF1 activity before experimental treatments even begin.

When interpreting data across different systems, clearly document experimental conditions, include system-specific controls, and acknowledge limitations in cross-system comparisons. Consider complementary approaches to validate key findings across different experimental models.

How can I investigate HSF1's role as a transcriptional repressor?

While HSF1 is primarily known as a transcriptional activator of heat shock genes, emerging evidence suggests it can also function as a transcriptional repressor. To investigate this repressive function:

• Chromatin immunoprecipitation (ChIP): Use HSF1 (Ab-142) Antibody for ChIP experiments to identify genomic regions where HSF1 binds as a potential repressor. Research has identified HSF1 binding to the surfactant protein D (SFTPD) promoter region, specifically at positions −142 to −134 bp, where it acts as a suppressor .

• Reporter gene assays: Construct reporters containing putative HSF1 repression sites (such as the SFTPD promoter region) and monitor expression changes with HSF1 manipulation. Research has shown that HSF1 suppresses SFTPD promoter activity specifically through the −142 to −134 bp region .

• Decoy oligonucleotide experiments: Use specific oligonucleotides mimicking HSF1 binding sites to compete with endogenous binding. Research demonstrated that a decoy oligonucleotide containing the HSF1 binding sequence relieved repression of the SFTPD promoter, while a mutated decoy had no effect .

• Transcriptome analysis: Compare gene expression profiles with and without HSF1 knockdown/overexpression to identify potential repressed targets. Look for genes that increase expression when HSF1 is depleted.

• Mechanistic studies: Investigate whether HSF1's repressive function involves recruitment of co-repressors or chromatin-modifying enzymes that promote a repressive chromatin state.

This emerging role of HSF1 as a repressor expands our understanding of its diverse functions beyond the canonical heat shock response and may have implications for various physiological and pathological processes .

How can I study the relationship between HSF1 and c-MYC transcriptional programs?

Recent research reveals that HSF1 specifically potentiates c-MYC-mediated transcription, distinct from its role in the canonical heat shock response . To investigate this interaction:

• Co-immunoprecipitation: Use HSF1 (Ab-142) Antibody to immunoprecipitate HSF1 and blot for c-MYC and associated cofactors like GCN5. Research indicates that HSF1 enhances the association between c-MYC and GCN5 . Similarly, immunoprecipitate c-MYC and blot for HSF1 to confirm the interaction.

• Gene expression analysis: Compare transcriptional changes in response to HSF1 manipulation (knockdown or overexpression) with known c-MYC target genes. Look for genes that respond to both HSF1 and c-MYC modulation.

• Histone acetylation analysis: Research suggests HSF1 enhances c-MYC transcriptional activity by promoting histone acetylation through facilitating c-MYC-GCN5 association . Examine how HSF1 status affects histone acetylation patterns at c-MYC target genes.

• c-MYC activation states: Investigate how HSF1 contributes to different c-MYC activation states (primary and advanced) and how these states relate to various physiological and pathological conditions .

• Functional consequences: Determine how the HSF1-c-MYC connection impacts cellular phenotypes relevant to cancer, such as proliferation, metabolism, and survival under stress conditions.

This HSF1-c-MYC relationship represents an important non-canonical function of HSF1 that may be particularly relevant in cancer contexts where both factors are frequently dysregulated . Understanding this mechanism could reveal new therapeutic opportunities for targeting c-MYC-driven cancers.

What are the non-phosphorylation mechanisms regulating HSF1 activity?

While phosphorylation has been extensively studied, research indicates other regulatory mechanisms play crucial roles in HSF1 function:

• Chaperone switch mechanism: The dynamic interaction between HSF1 and Hsp70 chaperones represents a key regulatory switch. Under basal conditions, Hsp70 (Ssa1/2) binds to HSF1, but during early heat shock, this interaction is transiently disrupted before being restored during recovery . This mechanism can be studied using co-immunoprecipitation with HSF1 (Ab-142) Antibody across a stress time course.

• Subcellular localization: HSF1 rapidly translocates from the cytoplasm to the nucleus during heat shock, forming discrete nuclear granules within seconds of stress exposure . This localization change can be studied using cellular fractionation followed by Western blot with HSF1 (Ab-142) Antibody or through immunofluorescence.

• DNA binding dynamics: Research shows that even a phosphorylation-deficient HSF1 mutant (with 152 out of 153 S/T residues mutated to alanine) maintained normal DNA binding capabilities across the genome . This suggests that DNA binding is regulated by mechanisms beyond phosphorylation.

• Post-translational modifications beyond phosphorylation: Other modifications like acetylation, SUMOylation, and ubiquitination may play important roles in HSF1 regulation. These can be studied using specific antibodies against these modifications after HSF1 immunoprecipitation.

• Protein-protein interactions: Beyond Hsp70, HSF1 likely interacts with various other proteins that influence its activity. Techniques like proximity labeling or mass spectrometry after immunoprecipitation can identify novel interacting partners.

Research with phosphorylation-deficient HSF1 mutants demonstrates that while phosphorylation contributes to HSF1 activity, the protein maintains critical functions even without phosphorylation . This highlights the importance of these alternative regulatory mechanisms and suggests multiple layers of control ensure proper HSF1 function during stress responses.